US Patent Issued on Sept. 30 for "4-[5-[(rac)-1-[5-(3-chlorophenyl)-3-isoxazolylethoxy-4-methyl-4H-1,2,4-triazol-3-ylpyridine for use in prevention and/or treatment of pain in an animal" (Swedish Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,140, issued on Sept. 30.

"4-[5-[(rac)-1-[5-(3-chlorophenyl)-3-isoxazolylethoxy-4-methyl-4H-1,2,4-triazol-3-ylpyridine for use in prevention and/or treatment of pain in an animal" was invented by Claes Thulin (Stockholm).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to 4-[5-[(rac)-1-[5-(3-Chlorophenyl)-3-isoxazolyl]ethoxy]-4-methyl-4H-1,2,4-triazol-3-yl]pyridine (TT00), or a pharmaceutically acceptable salt thereof, diastereomer, enantiomer, isotope, pro-drug or metabolite or mixture thereof, or a pharmaceutical composition comprising said TT00, for use in prevention and/or treatment of pain, such as chronic and/or peri...